SE9600216D0 - Styrning av läkningsprocesser - Google Patents

Styrning av läkningsprocesser

Info

Publication number
SE9600216D0
SE9600216D0 SE9600216A SE9600216A SE9600216D0 SE 9600216 D0 SE9600216 D0 SE 9600216D0 SE 9600216 A SE9600216 A SE 9600216A SE 9600216 A SE9600216 A SE 9600216A SE 9600216 D0 SE9600216 D0 SE 9600216D0
Authority
SE
Sweden
Prior art keywords
control
healing processes
wound healing
chitosans
fibrin
Prior art date
Application number
SE9600216A
Other languages
English (en)
Swedish (sv)
Inventor
Hans-Arne Hansson
Original Assignee
Hans Arne Hansson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hans Arne Hansson filed Critical Hans Arne Hansson
Priority to SE9600216A priority Critical patent/SE9600216D0/xx
Publication of SE9600216D0 publication Critical patent/SE9600216D0/xx
Priority to CA002241983A priority patent/CA2241983A1/en
Priority to KR1019980705478A priority patent/KR19990077331A/ko
Priority to AT97900852T priority patent/ATE214280T1/de
Priority to HU9902029A priority patent/HUP9902029A3/hu
Priority to NZ326003A priority patent/NZ326003A/en
Priority to US09/101,351 priority patent/US6174855B1/en
Priority to CZ982250A priority patent/CZ225098A3/cs
Priority to CN97193027A priority patent/CN1213309A/zh
Priority to AU13271/97A priority patent/AU701260B2/en
Priority to BR9707005A priority patent/BR9707005A/pt
Priority to PCT/SE1997/000057 priority patent/WO1997025994A1/en
Priority to DE69711024T priority patent/DE69711024T2/de
Priority to JP52591797A priority patent/JP4112006B2/ja
Priority to PL97327828A priority patent/PL327828A1/xx
Priority to TR1998/01365T priority patent/TR199801365T2/xx
Priority to EP97900852A priority patent/EP0874634B1/en
Priority to IL12537597A priority patent/IL125375A0/xx
Priority to IS4782A priority patent/IS4782A/is
Priority to NO983295A priority patent/NO983295L/no
Priority to JP2008033125A priority patent/JP2008163036A/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/047—Other specific proteins or polypeptides not covered by A61L31/044 - A61L31/046
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A61K38/166—Streptokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A61K38/58—Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Control Of Temperature (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • General Induction Heating (AREA)
  • Control Of Steam Boilers And Waste-Gas Boilers (AREA)
  • Controlling Rewinding, Feeding, Winding, Or Abnormalities Of Webs (AREA)
  • Control Of Metal Rolling (AREA)
  • Moulding By Coating Moulds (AREA)
  • Manufacture, Treatment Of Glass Fibers (AREA)
  • Electrotherapy Devices (AREA)
SE9600216A 1996-01-18 1996-01-18 Styrning av läkningsprocesser SE9600216D0 (sv)

Priority Applications (21)

Application Number Priority Date Filing Date Title
SE9600216A SE9600216D0 (sv) 1996-01-18 1996-01-18 Styrning av läkningsprocesser
IL12537597A IL125375A0 (en) 1996-01-18 1997-01-16 Control of healing process
CN97193027A CN1213309A (zh) 1996-01-18 1997-01-16 愈合方法的控制
BR9707005A BR9707005A (pt) 1996-01-18 1997-01-16 Uso de um inibidor de trombina prosessos de controle de processos de cura de ferida dentro do corpo de inibição ou de prevenção de ades o relacionada a fibrina e de inibição ou de prevenção de formação de tecido cicatriz e produto farmacêutico
AT97900852T ATE214280T1 (de) 1996-01-18 1997-01-16 Steuerung des heilungsprozesses
HU9902029A HUP9902029A3 (en) 1996-01-18 1997-01-16 Control of healing process
NZ326003A NZ326003A (en) 1996-01-18 1997-01-16 Control of healing process using hirudine, a thrombin inhibitor or a fibrinolytic agent
US09/101,351 US6174855B1 (en) 1996-01-18 1997-01-16 Pharmaceutical compositions comprising thrombin inhibitors and their use in the control of wound healing processes
CZ982250A CZ225098A3 (cs) 1996-01-18 1997-01-16 Řízení hojivého procesu
CA002241983A CA2241983A1 (en) 1996-01-18 1997-01-16 Control of healing process
AU13271/97A AU701260B2 (en) 1996-01-18 1997-01-16 Control of healing process
KR1019980705478A KR19990077331A (ko) 1996-01-18 1997-01-16 치유 과정의 관리
PCT/SE1997/000057 WO1997025994A1 (en) 1996-01-18 1997-01-16 Control of healing process
DE69711024T DE69711024T2 (de) 1996-01-18 1997-01-16 Steuerung des heilungsprozesses
JP52591797A JP4112006B2 (ja) 1996-01-18 1997-01-16 治癒過程の調節
PL97327828A PL327828A1 (en) 1996-01-18 1997-01-16 Wound healing process control
TR1998/01365T TR199801365T2 (xx) 1996-01-18 1997-01-16 �yile�me s�recinin kontrol�.
EP97900852A EP0874634B1 (en) 1996-01-18 1997-01-16 Control of healing process
IS4782A IS4782A (is) 1996-01-18 1998-06-24 Stýring græðsluferlis
NO983295A NO983295L (no) 1996-01-18 1998-07-16 Kontroll av helingsprosess
JP2008033125A JP2008163036A (ja) 1996-01-18 2008-02-14 治癒過程の調節

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9600216A SE9600216D0 (sv) 1996-01-18 1996-01-18 Styrning av läkningsprocesser

Publications (1)

Publication Number Publication Date
SE9600216D0 true SE9600216D0 (sv) 1996-01-18

Family

ID=20401098

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9600216A SE9600216D0 (sv) 1996-01-18 1996-01-18 Styrning av läkningsprocesser

Country Status (20)

Country Link
US (1) US6174855B1 (zh)
EP (1) EP0874634B1 (zh)
JP (2) JP4112006B2 (zh)
KR (1) KR19990077331A (zh)
CN (1) CN1213309A (zh)
AT (1) ATE214280T1 (zh)
AU (1) AU701260B2 (zh)
BR (1) BR9707005A (zh)
CA (1) CA2241983A1 (zh)
CZ (1) CZ225098A3 (zh)
DE (1) DE69711024T2 (zh)
HU (1) HUP9902029A3 (zh)
IL (1) IL125375A0 (zh)
IS (1) IS4782A (zh)
NO (1) NO983295L (zh)
NZ (1) NZ326003A (zh)
PL (1) PL327828A1 (zh)
SE (1) SE9600216D0 (zh)
TR (1) TR199801365T2 (zh)
WO (1) WO1997025994A1 (zh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9900043D0 (sv) * 1999-01-11 1999-01-11 Astra Ab New use
SE9900070D0 (sv) 1999-01-13 1999-01-13 Astra Ab New use
ATE550073T1 (de) 2001-06-13 2012-04-15 Univ Sydney Protein c für die wundheilung
US7202066B2 (en) * 2002-01-29 2007-04-10 Carrington Laboratories, Inc. Combination of a growth factor and a protease enzyme
JPWO2005037292A1 (ja) * 2003-10-21 2006-12-28 株式会社ネーテック 糖鎖含有キトサン誘導体を含有する内視鏡手術用粘膜下膨隆液組成物
US7795205B2 (en) * 2004-04-12 2010-09-14 Canyon Pharmaceuticals, Inc. Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor
US9119901B2 (en) 2005-04-28 2015-09-01 Warsaw Orthopedic, Inc. Surface treatments for promoting selective tissue attachment to medical impants
US8414907B2 (en) 2005-04-28 2013-04-09 Warsaw Orthopedic, Inc. Coatings on medical implants to guide soft tissue healing
US7450296B2 (en) 2006-01-30 2008-11-11 Taiwan Semiconductor Manufacturing Company, Ltd. Method and system for patterning alignment marks on a transparent substrate
US8697387B2 (en) * 2006-06-02 2014-04-15 DiscoverRx Corporation Methods for identifying agents and their use for the prevention of restenosis
AU2012252165A1 (en) 2011-05-09 2013-03-21 Cambridge Enterprise Limited Methods of modulating micrornas in the treatment of pulmonary arterial hypertension
DE102014112212A1 (de) 2014-08-26 2016-03-03 Akesion Gmbh Rekombinante Fusionsproteine zur Vorbeugung oder Behandlung von Adhäsionen bei Geweben oder Organen
US20200054719A1 (en) * 2016-11-02 2020-02-20 Erik Ian Tucker E-we thrombin analog and fibrinolytic combination
CN106729676A (zh) * 2016-12-07 2017-05-31 杭州市萧山区中医院 水蛭素用于制备治疗术后肌腱粘连的药物中的应用
JP7264589B2 (ja) * 2017-12-25 2023-04-25 株式会社 資生堂 トロンビンの抑制作用を指標とした皮膚状態改善剤のスクリーニング方法、及びトロンビン作用阻害剤を含む皮膚状態改善剤

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4326532A (en) * 1980-10-06 1982-04-27 Minnesota Mining And Manufacturing Company Antithrombogenic articles
US4532134A (en) * 1981-04-06 1985-07-30 Malette William Graham Method of achieving hemostasis, inhibiting fibroplasia, and promoting tissue regeneration in a tissue wound
JPS61253065A (ja) * 1985-05-02 1986-11-10 片倉チツカリン株式会社 キトサン誘導体およびコラ−ゲンの複合材の医用材料およびその製造法
US5112608A (en) * 1987-03-13 1992-05-12 Incyte Pharmaceuticals Use of protease nexin-I to mediate wound healing
NL8902406A (nl) * 1989-09-27 1991-04-16 Hendrik Coenraad Hemker Prof D Werkwijze voor het bepalen van de endogene trombinepotentiaal van plasma, en bloed alsmede een bij deze werkwijze te gebruiken kit.
EP0426368B1 (en) * 1989-10-31 1995-01-04 Howmedica Inc. Compositions containing derivatives of chitin for preventing adhesion
US5209776A (en) 1990-07-27 1993-05-11 The Trustees Of Columbia University In The City Of New York Tissue bonding and sealing composition and method of using the same
JPH04112006A (ja) * 1990-08-31 1992-04-14 Seiji Ichikawa セメント液作成方法
US5792835A (en) * 1991-09-05 1998-08-11 Baxter International Inc. Method of preparing a topical fibrinogen complex
SE9103612D0 (sv) * 1991-12-04 1991-12-04 Astra Ab New peptide derivatives
DE4200080A1 (de) * 1992-01-03 1993-09-30 Reinmueller Johannes Pharmazeutische Zusammensetzung zur Wund-, Narben- und Keloidbehandlung
SE9301916D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptides derivatives

Also Published As

Publication number Publication date
BR9707005A (pt) 1999-07-20
PL327828A1 (en) 1999-01-04
JP4112006B2 (ja) 2008-07-02
AU1327197A (en) 1997-08-11
IL125375A0 (en) 1999-03-12
NO983295D0 (no) 1998-07-16
CZ225098A3 (cs) 1998-10-14
HUP9902029A2 (hu) 1999-11-29
HUP9902029A3 (en) 2001-01-29
EP0874634B1 (en) 2002-03-13
AU701260B2 (en) 1999-01-21
WO1997025994A1 (en) 1997-07-24
NZ326003A (en) 2001-03-30
ATE214280T1 (de) 2002-03-15
CN1213309A (zh) 1999-04-07
CA2241983A1 (en) 1997-07-24
JP2000503318A (ja) 2000-03-21
DE69711024T2 (de) 2002-09-19
EP0874634A1 (en) 1998-11-04
KR19990077331A (ko) 1999-10-25
DE69711024D1 (de) 2002-04-18
NO983295L (no) 1998-07-16
US6174855B1 (en) 2001-01-16
JP2008163036A (ja) 2008-07-17
IS4782A (is) 1998-06-24
TR199801365T2 (xx) 1998-10-21

Similar Documents

Publication Publication Date Title
SE9600216D0 (sv) Styrning av läkningsprocesser
IL131348A0 (en) Treatment and prevention of adhesions
EP1273298A3 (en) Ritonavir in combination with an additional HIV protease inhibitor for treating aids
EP1776954A3 (en) The use of inhibitors of the renin-angiotensin system for the treatment of stroke
IL135921A0 (en) Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
IL110943A (en) Compositions comprising an inhibitor of cholesterol synthesis for the treatment of skin disorders
ATE318141T1 (de) Verwendung von taurolidin oder taurultam zur herstellung eines arzneimittels zur vorbeugung von metastasen
DK0772446T3 (da) Anti-adhæsionsmiddel
AU1023497A (en) Tissue factor - kunitz domain fusion proteins as factor viia inhibitors
EP0870502A3 (en) Use of adenosine uptake inhibitors for the manufacture of a medicament for the treatment of pancreatitis
EP1110556A4 (en) PREVENTIVE DRUGS / AND REMEDIES AGAINST MULTIPLE ORGANS FAILURE
NO20030841L (no) En ny spesifikk mekanisme for inhibering av blodplateadhesjon til kollagen
NO934653L (no) Anvendelse av trombininhibitorer for inhibitering av okkular fibrindannelse
CA2149209A1 (en) Use of Topically Applied Factor XIII for Inhibiting Hemorrhage
AU1569700A (en) Novel therapeutic application of low molecular weight heparin
IS5231A (is) Vefjaþáttur sem hefur áhrif á blóðæðarmyndun
WO2002005796A3 (en) Use of a spla2 inhibitor for the treatment of sepsis
DK0895478T3 (da) Bestanddel B som ardanner
MX9801622A (es) Biomateriales comprendidos de derivados de acido hialuronico para prevenir las adhesiones post-quirurgicas.